Article Name Invitro Diagnostic

BD receive US FDA approval for Onclarity HPV assay

HPV primary testing without the need for a traditional Pap smear performed with a speculum...Read more

15th May, 2024


BGI establishes intelligent lab in China for initiating colorectal cancer risk assessment

For managing chronic diseases and shaping future medical practices...Read more

13th May, 2024


Beckman Coulter and MeMed extend partnership advancing host immune response diagnostics

Beckman Coulter now an authorised distributor of MeMed key immunoassay system and MeMed BV assay...Read more

07th May, 2024


MGI Tech opens customer experience center in Brazil

To contribute to the advancement of genomics in Latin America...Read more

28th April, 2024


Strand Life Sciences announces launch of prenatal genomic diagnostics portfolio

Advanced tests based on a genomic analysis pipeline specifically developed and validated on Indian samples and conditions ...Read more

24th April, 2024


Roche Diagnostics India launches heart failure test for diabetics as point-of-care device

Offers faster testing, early risk identification, thereby improving disease management...Read more

10th April, 2024


Beckman Coulter Introduces DxC 500 AU Chemistry Analyzer, Enhances Portfolio with Six Sigma Performance

New analyzer complements hub labs by advancing capabilities of satellite and independent community hospital labs...Read more

30th January, 2024


Fujirebio and Agappe Forge Strategic Partnership in CLIA-Based Immunoassay Solutions

In a groundbreaking initiative, Fujirebio Holdings, Inc. and Agappe Diagnostics Ltd have joined forces in a Contract Development and Manufacturing Organization (CDMO) collaboration focused on advancing Cartridge-based CL...Read more

20th January, 2024


“The Open Innovation Program has become a trend in the molecular diagnostics industry”

Established in 2000, South Korea based Seegene Inc is a leader in molecular diagnostics and achieved remarkable financial success with over $1 billion in revenue and 65 per cent gross margins. With a mission for a diseas...Read more

08th January, 2024


In Vitro Diagnostics Market Expected to Reach USD 124.65 Billion by 2032

According to a recent report by Precedence Research, the global in vitro diagnostics (IVD) market is projected to reach approximately USD 124.65 billion by 2032, witnessing a substantial increase from USD 107.76 billion ...Read more

11th December, 2023


© 2023 MM Activ Sci-Tech Communications. All rights reserved | Disclaimer